Medicenna TherapeuticsCorp Buy Hold or Sell Recommendation

MDNADelisted Stock  USD 0.31  0.00  0.00%   
Given the investment horizon of 90 days and your conservative attitude towards risk, our recommendation regarding Medicenna TherapeuticsCorp is 'Not Rated'. Macroaxis provides Medicenna TherapeuticsCorp buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MDNA positions. The advice algorithm takes into account all of Medicenna TherapeuticsCorp's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Medicenna TherapeuticsCorp's buy or sell advice are summarized below:
Real Value
0.26
Hype Value
0.31
Market Value
0.31
Naive Value
0.35
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Medicenna TherapeuticsCorp given historical horizon and risk tolerance towards Medicenna TherapeuticsCorp. When Macroaxis issues a 'buy' or 'sell' recommendation for Medicenna TherapeuticsCorp, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
In addition, we conduct extensive research on individual companies such as Medicenna and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Medicenna TherapeuticsCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Execute Medicenna TherapeuticsCorp Buy or Sell Advice

The Medicenna recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medicenna TherapeuticsCorp. Macroaxis does not own or have any residual interests in Medicenna TherapeuticsCorp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medicenna TherapeuticsCorp's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Medicenna TherapeuticsCorpBuy Medicenna TherapeuticsCorp
Not Rated
For the selected time horizon Medicenna TherapeuticsCorp has a Risk Adjusted Performance of 0.0378, Jensen Alpha of 0.4358, Total Risk Alpha of (0.75), Sortino Ratio of 0.0394 and Treynor Ratio of (1.02)
We provide investment recommendation to complement the last-minute expert consensus on Medicenna TherapeuticsCorp. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Medicenna TherapeuticsCorp is not overpriced, please verify all Medicenna TherapeuticsCorp fundamentals, including its shares owned by institutions, cash per share, earnings per share, as well as the relationship between the ebitda and book value per share . As Medicenna TherapeuticsCorp appears to be a penny stock we also strongly suggest to check its number of shares shorted numbers.

Medicenna TherapeuticsCorp Trading Alerts and Improvement Suggestions

Medicenna TherapeuticsCorp is not yet fully synchronised with the market data
Medicenna TherapeuticsCorp has some characteristics of a very speculative penny stock
Medicenna TherapeuticsCorp has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (10.05 M) with profit before overhead, payroll, taxes, and interest of 0.
Medicenna TherapeuticsCorp currently holds about 19.3 M in cash with (12.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders

Medicenna TherapeuticsCorp Returns Distribution Density

The distribution of Medicenna TherapeuticsCorp's historical returns is an attempt to chart the uncertainty of Medicenna TherapeuticsCorp's future price movements. The chart of the probability distribution of Medicenna TherapeuticsCorp daily returns describes the distribution of returns around its average expected value. We use Medicenna TherapeuticsCorp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medicenna TherapeuticsCorp returns is essential to provide solid investment advice for Medicenna TherapeuticsCorp.
Mean Return
0.41
Value At Risk
-11.11
Potential Upside
12.82
Standard Deviation
8.97
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medicenna TherapeuticsCorp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Medicenna TherapeuticsCorp Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medicenna . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Medicenna TherapeuticsCorp Buy or Sell Advice

When is the right time to buy or sell Medicenna TherapeuticsCorp? Buying financial instruments such as Medicenna Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Medicenna TherapeuticsCorp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Commodities ETFs Thematic Idea Now

Broad Commodities ETFs
Broad Commodities ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Commodities ETFs theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Commodities ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Medicenna Stock

If you are still planning to invest in Medicenna TherapeuticsCorp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medicenna TherapeuticsCorp's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings